Literature DB >> 9450968

Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability.

K P Claffey1, S C Shih, A Mullen, S Dziennis, J L Cusick, K R Abrams, S W Lee, M Detmar.   

Abstract

Hypoxia is a prominent feature of malignant tumors that are characterized by angiogenesis and vascular hyperpermeability. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) has been shown to be up-regulated in the vicinity of necrotic tumor areas, and hypoxia potently induces VPF/VEGF expression in several tumor cell lines in vitro. Here we report that hypoxia-induced VPF/VEGF expression is mediated by increased transcription and mRNA stability in human M21 melanoma cells. RNA-binding/electrophoretic mobility shift assays identified a single 125-bp AU-rich element in the 3' untranslated region that formed hypoxia-inducible RNA-protein complexes. Hypoxia-induced expression of chimeric luciferase reporter constructs containing this 125-bp AU-rich hypoxia stability region were significantly higher than constructs containing an adjacent 3' untranslated region element without RNA-binding activity. Using UV-cross-linking studies, we have identified a series of hypoxia-induced proteins of 90/88 kDa, 72 kDa, 60 kDa, 56 kDa, and 46 kDa that bound to the hypoxia stability region element. The 90/88-kDa and 60-kDa species were specifically competed by excess hypoxia stability region RNA. Thus, increased VPF/VEGF mRNA stability induced by hypoxia is mediated, at least in part, by specific interactions between a defined mRNA stability sequence in the 3' untranslated region and distinct mRNA-binding proteins in human tumor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9450968      PMCID: PMC25276          DOI: 10.1091/mbc.9.2.469

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  71 in total

1.  Predicting optimal and suboptimal secondary structure for RNA.

Authors:  J A Jaeger; D H Turner; M Zuker
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.

Authors:  H F Dvorak; J A Nagy; B Berse; L F Brown; K T Yeo; T K Yeo; A M Dvorak; L van de Water; T M Sioussat; D R Senger
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

3.  Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor.

Authors:  G Conn; M L Bayne; D D Soderman; P W Kwok; K A Sullivan; T M Palisi; D A Hope; K A Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  An endothelial cell growth factor from the mouse neuroblastoma cell line NB41.

Authors:  A P Levy; R Tamargo; H Brem; D Nathans
Journal:  Growth Factors       Date:  1989       Impact factor: 2.511

5.  Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1.

Authors:  W Zhang; B J Wagner; K Ehrenman; A W Schaefer; C T DeMaria; D Crater; K DeHaven; L Long; G Brewer
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia.

Authors:  G L Wang; G L Semenza
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

7.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

Authors:  L F Brown; B Berse; R W Jackman; K Tognazzi; E J Manseau; D R Senger; H F Dvorak
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

8.  Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.

Authors:  L F Brown; B Berse; R W Jackman; K Tognazzi; E J Manseau; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

9.  Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart.

Authors:  A Ladoux; C Frelin
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

10.  Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells.

Authors:  M F Czyzyk-Krzeska; B A Furnari; E E Lawson; D E Millhorn
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

View more
  35 in total

1.  VEGF expression by epithelial and stromal cell compartments: resolving a controversy.

Authors:  D R Senger; L Van De Water
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

2.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

3.  Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.

Authors:  Nadia Cherradi; Cyrille Lejczak; Agnes Desroches-Castan; Jean-Jacques Feige
Journal:  Mol Endocrinol       Date:  2005-11-23

4.  MDM2 regulates vascular endothelial growth factor mRNA stabilization in hypoxia.

Authors:  Sheng Zhou; Lubing Gu; Jing He; Hailong Zhang; Muxiang Zhou
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

5.  Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L.

Authors:  Faegheh Jafarifar; Peng Yao; Sandeepa M Eswarappa; Paul L Fox
Journal:  EMBO J       Date:  2011-02-22       Impact factor: 11.598

6.  Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype.

Authors:  Débora S Faffe; Lesley Flynt; Kerri Bourgeois; Reynold A Panettieri; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-06       Impact factor: 6.914

7.  Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization.

Authors:  Chyi-Ying A Chen; Nianhua Xu; Ann-Bin Shyu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Antagonistic function of the RNA-binding protein HuR and miR-200b in post-transcriptional regulation of vascular endothelial growth factor-A expression and angiogenesis.

Authors:  Sung-Hee Chang; Yi-Chien Lu; Xi Li; Wan-Ying Hsieh; Yuquan Xiong; Mallika Ghosh; Todd Evans; Olivier Elemento; Timothy Hla
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

9.  A stress-responsive RNA switch regulates VEGFA expression.

Authors:  Partho Sarothi Ray; Jie Jia; Peng Yao; Mithu Majumder; Maria Hatzoglou; Paul L Fox
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

Review 10.  Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements.

Authors:  Khalid S A Khabar
Journal:  Cell Mol Life Sci       Date:  2010-05-22       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.